Shingo Ishimori

838 total citations
47 papers, 392 citations indexed

About

Shingo Ishimori is a scholar working on Molecular Biology, Nephrology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shingo Ishimori has authored 47 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 19 papers in Nephrology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shingo Ishimori's work include Renal Diseases and Glomerulopathies (13 papers), Renal and related cancers (10 papers) and Cell Adhesion Molecules Research (10 papers). Shingo Ishimori is often cited by papers focused on Renal Diseases and Glomerulopathies (13 papers), Renal and related cancers (10 papers) and Cell Adhesion Molecules Research (10 papers). Shingo Ishimori collaborates with scholars based in Japan, Indonesia and United States. Shingo Ishimori's co-authors include Kazumoto Iijima, Kandai Nozu, Koichi Nakanishi, Hiroshi Kaito, Takeshi Ninchoji, Tomohiko Yamamura, Tomoko Horinouchi, Naoya Morisada, Norishige Yoshikawa and Yuko Shima and has published in prestigious journals such as Scientific Reports, Kidney International and Nephrology Dialysis Transplantation.

In The Last Decade

Shingo Ishimori

41 papers receiving 376 citations

Peers

Shingo Ishimori
Shingo Ishimori
Citations per year, relative to Shingo Ishimori Shingo Ishimori (= 1×) peers Yuya Hashimura

Countries citing papers authored by Shingo Ishimori

Since Specialization
Citations

This map shows the geographic impact of Shingo Ishimori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shingo Ishimori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shingo Ishimori more than expected).

Fields of papers citing papers by Shingo Ishimori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shingo Ishimori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shingo Ishimori. The network helps show where Shingo Ishimori may publish in the future.

Co-authorship network of co-authors of Shingo Ishimori

This figure shows the co-authorship network connecting the top 25 collaborators of Shingo Ishimori. A scholar is included among the top collaborators of Shingo Ishimori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shingo Ishimori. Shingo Ishimori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aoto, Yuya, et al.. (2025). Clinical and Genetic Insights Into Isolated Proteinuria With CUBN Variants. Kidney International Reports. 11(3). 103754–103754.
2.
Tanaka, Yu, China Nagano, Eri Okada, et al.. (2025). Phenotype and genotype of autosomal dominant tubulointerstitial kidney disease in a Japanese cohort. Clinical and Experimental Nephrology. 29(6). 788–796. 1 indexed citations
3.
Ishimori, Shingo, Yuka Kimura, Yu Tanaka, et al.. (2025). Impact of Age-3 Urine Screening on Diagnosis and Treatment Timing in Alport Syndrome. Kidney International Reports. 10(12). 4234–4240.
4.
Tanaka, Yu, China Nagano, Tomoko Horinouchi, et al.. (2025). Clinical characteristics of patients with SALL1-related disorder. Pediatric Nephrology. 40(11). 3407–3414.
5.
Tanaka, Yu, China Nagano, Tomoko Horinouchi, et al.. (2025). The first case of Al-Raqad syndrome in Japan is associated with a homozygous DCPS exonic variant resulting in aberrant splicing. Brain and Development. 47(4). 104366–104366.
6.
Suzuki, Ryota, Nana Sakakibara, Yu Tanaka, et al.. (2024). Genotype and X-chromosome inactivation are associated with disease severity in females with X-linked Alport syndrome. Nephrology Dialysis Transplantation. 40(4). 688–695. 1 indexed citations
7.
Ishimori, Shingo, Tomoko Horinouchi, Tomohiko Yamamura, et al.. (2024). Role of Iron in Children With Immunoglobulin A Nephropathy and Macrohematuria-Induced Acute Kidney Injury. Kidney International Reports. 9(6). 1664–1673. 1 indexed citations
8.
Sakakibara, Nana, China Nagano, Yu Tanaka, et al.. (2024). In steroid-resistant nephrotic syndrome that meets the strict definition, monogenic variants are less common than expected. Pediatric Nephrology. 39(12). 3497–3503. 2 indexed citations
9.
Horinouchi, Tomoko, Yu Tanaka, Atsushi Kondo, et al.. (2024). Clinical characteristics and outcomes of immune-complex membranoproliferative glomerulonephritis and C3 glomerulopathy in Japanese children. Pediatric Nephrology. 39(9). 2679–2689. 2 indexed citations
10.
Horinouchi, Tomoko, Takeshi Ninchoji, Yu Tanaka, et al.. (2023). Long-term outcome of combination therapy with corticosteroids, mizoribine and RAS inhibitors as initial therapy for severe childhood IgA vasculitis with nephritis. Pediatric Nephrology. 38(12). 4023–4031. 2 indexed citations
11.
Horinouchi, Tomoko, Takeshi Ninchoji, Atsushi Kondo, et al.. (2022). Use of renin-angiotensin system inhibitors as initial therapy in children with Henoch–Schönlein purpura nephritis of moderate severity. Pediatric Nephrology. 37(8). 1845–1853. 2 indexed citations
12.
Ishimori, Shingo, Tomoko Horinouchi, Junya Fujimura, et al.. (2022). Is influenza vaccination associated with nephrotic syndrome relapse in children? A multicenter prospective study. Pediatric Nephrology. 38(7). 2107–2116. 1 indexed citations
14.
Yamamura, Tomohiko, Tomoko Horinouchi, China Nagano, et al.. (2020). Genotype-phenotype correlations influence the response to angiotensin-targeting drugs in Japanese patients with male X-linked Alport syndrome. Kidney International. 98(6). 1605–1614. 63 indexed citations
15.
Ishimori, Shingo, Koichi Kamei, Takashi Ando, et al.. (2020). Influenza virus vaccination in children with nephrotic syndrome: insignificant risk of relapse. Clinical and Experimental Nephrology. 24(11). 1069–1076. 9 indexed citations
16.
Ninchoji, Takeshi, Kandai Nozu, Keita Nakanishi, et al.. (2017). Clinical characteristics and long-term outcome of diarrhea-associated hemolytic uremic syndrome: a single center experience. Clinical and Experimental Nephrology. 21(5). 889–894. 8 indexed citations
17.
Yamamura, Tomohiko, Naoya Morisada, Kandai Nozu, et al.. (2016). Rare renal ciliopathies in non-consanguineous families that were identified by targeted resequencing. Clinical and Experimental Nephrology. 21(1). 136–142. 9 indexed citations
18.
Hashimura, Yuya, Kandai Nozu, Hiroshi Kaito, et al.. (2013). Milder clinical aspects of X-linked Alport syndrome in men positive for the collagen IV α5 chain. Kidney International. 85(5). 1208–1213. 54 indexed citations
19.
Kamei, Koichi, Masao Ogura, Shingo Ishimori, et al.. (2013). Acute kidney injury after acute gastroenteritis in an infant with hereditary hypouricemia. European Journal of Pediatrics. 173(2). 247–249. 5 indexed citations
20.
Nishiumi, Shin, Osamu Miyake, Shingo Ishimori, et al.. (2012). Metabolomics analysis of umbilical cord blood clarifies changes in saccharides associated with delivery method. Early Human Development. 89(5). 315–320. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026